Medpace Holdings Inc. (MEDP)
This Clinical Trials Stock Just Soared 40%. What Caused It to Pop.
If gains hold, that'd be the stock's largest single-day increase on record.
Medpace (MEDP) Q2 Earnings and Revenues Surpass Estimates
Medpace (MEDP) came out with quarterly earnings of $3.1 per share, beating the Zacks Consensus Estimate of $3 per share. This compares to earnings of $2.75 per share a year ago.
Medpace (MEDP) Beats Stock Market Upswing: What Investors Need to Know
Medpace (MEDP) reached $319.16 at the closing of the latest trading day, reflecting a +1.38% change compared to its last close.
Medpace (MEDP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Medpace (MEDP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Medpace (MEDP) Exceeds Market Returns: Some Facts to Consider
In the closing of the recent trading day, Medpace (MEDP) stood at $328.24, denoting a +2.27% move from the preceding trading day.
Medpace (MEDP) Exceeds Market Returns: Some Facts to Consider
Medpace (MEDP) closed the most recent trading day at $326.03, moving +1.55% from the previous trading session.
Medpace (MEDP) Stock Dips While Market Gains: Key Facts
Medpace (MEDP) closed the most recent trading day at $306.8, moving 1.39% from the previous trading session.
Medpace (MEDP) Exceeds Market Returns: Some Facts to Consider
Medpace (MEDP) closed the most recent trading day at $305.90, moving +2.54% from the previous trading session.
Medpace Holdings, Inc. (MEDP) Q1 2025 Earnings Call Transcript
Medpace Holdings, Inc. (NASDAQ:MEDP ) Q1 2025 Earnings Conference Call April 22, 2025 9:00 AM ET Company Participants Lauren Morris - Director, Investor Relations August Troendle - Chief Executive Officer Jesse Geiger - President Kevin Brady - Chief Financial Officer Conference Call Participants David Windley - Jefferies Max Smock - William Blair Ann Hynes - Mizuho Dan Leonard - UBS Eric Coldwell - Baird Charles Rhyee - TD Cowen Michael Cherny - Leerink Partners Jailendra Singh - Truist Securities Justin Bowers - Deutsche Bank Operator Good day, ladies and gentlemen, and welcome to the Medpace First Quarter 2025 Earnings Conference Call. At this time all participants are in a listen-only mode.
Medpace (MEDP) Q1 Earnings and Revenues Beat Estimates
Medpace (MEDP) came out with quarterly earnings of $3.67 per share, beating the Zacks Consensus Estimate of $3.06 per share. This compares to earnings of $3.20 per share a year ago.
Analysts Estimate Medpace (MEDP) to Report a Decline in Earnings: What to Look Out for
Medpace (MEDP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Medpace (MEDP) Ascends While Market Falls: Some Facts to Note
In the latest trading session, Medpace (MEDP) closed at $290.10, marking a +1.04% move from the previous day.
